Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults

Journal of Infectious Diseases

Volumn 173, Issue 5, 1996, Pages 1242-1247

  Grogan, Jane L ^b   Kremsner, Peter G ^b   Van Dam, Govert J ^b   Metzger, Wolfram ^b   Mordmüller, Benjamin ^b   Decider, André M ^b   Yazdanbakhsh, Maria ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 4; MONOCLONAL ANTIBODY CD3; PARASITE ANTIBODY; PARASITE ANTIGEN; POLYCLONAL ANTIBODY; PRAZIQUANTEL;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; BLOOD SMEAR; CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; INTERFERON PRODUCTION; MAJOR CLINICAL STUDY; MALE; PARASITE IDENTIFICATION; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SCHOOL CHILD;

EID: 0029994531     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.5.1242     Document Type: Article

References (29)

1. Butterworth AE, Dunne DW, Fulford AJC, Thorne KJI. Human immunity to Schistosoma mansoni: observations on mechanisms and implications for control. Immunol Invest 1992;21:391-407.
2. Butterworth AE, Bensted-Smith R, Capron A, et al. Immunity in human schistosomiasis: prevention by blocking antibodies of the expression of immunity in young children. Parasitology 1987;94:281-300.
3. Dessein AJ, Couissinier P, Demeure CE, et al. Environmental, genetic, and immunological factors in human resistance to Schistosoma mansoni. Immunol Invest 1992;21:423-53.
4. Hagan P, Blumenthal UJ, Dunn D, Simpson AJG, Wilkins HA. Human IgE, IgG4, and resistance to reinfection with Schistosoma haematobium. Nature 1991;349:243-5.
5. Demeure CE, Rihet P, Abel L, Ouattara M, Bourgois A, Dessein AJ. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infect Dis 1993;168:1000-8.
6. Dunne DW, Grabowska AM, Fulford AJC, et al. Human antibody responses to Schistosoma mansoni: the influence of epitopes shared between different life cycle stages on the response to the schistosomulum. Eur J Immunol 1988;18:123-31.
7. Dunne DW, Butterworth AE, Fulford AJC, et al. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol 1992;22:1483-94.
8. Iskander R, Das PK, Aalberse RC. IgG4 antibodies in Egyptian patients with schistosomiasis. Int Arch Allergy Appl Immunol 1981;66:200-7.
9. Rihet P, Demeure CE, Dessein AJ, Bourgois A. Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a Schistosoma mansoni endemic area. Eur J Immunol 1992;22:2063-70.
10. Rihet P, Demeure CE, Bourgois A, Prata A, Dessein AJ. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol 1991;21:2679-86.
11. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;9:145-73.
12. De Vries JE, Gauchat JF, Aversa GG, Punnonen J, Gascan H, Yssel H. Regulation of IgE synthesis by cytokines. Curr Opin Immunol 1990;3:851-8.
13. Mahanty S, King CL, Kumaraswami V, et al. IL-4- and IL-5-secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. J Immunol 1993;151:3704-11.
14. Nutman TB, Kumaraswami V, Ottesen EA. Parasite-specific anergy in human filariasis. Insights after analysis of parasite antigen-driven lymphokine production. J Clin Invest 1987;79:1516-23.
15. Kumiawan A, Yazdanbakhsh M, van Ree R, et al. Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis. J Immunol 1993;150:3941-50.
16. Sartono E, Kruize YCM, Kurniawan A, et al. Elevated cellular immune responses and Interferon-γ release after long-term diethylcarbamazine treatment of patients with human lymphatic filariasis. J Infect Dis 1995;171:1683-7.
17. Elson LH, Calvopina M, Paredes W, et al. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. J Infect Dis 1995;171:652-8.
18. Kremsner PG, Enyong P, Krijger FW, et al. Circulating anodic and cathodic antigen in serum and urine from Schistosoma haematobium-infected Cameroonian children receiving praziquantel: a longitudinal study. Clin Infect Dis 1994;18:408-13.
19. Browne HG, Thomas JI. A method for isolating pure viable schistosome eggs from host tissues. Exp Parasitol 1963;49:371-4.
20. Decider AM, De Jonge N, Boerman OC, et al. Sensitive determination of circulating anodic antigen in Schistosoma mansoni infected individuals by an enzyme-linked immunosorbent assay using monoclonal antibodies. Am J Trop Med Hyg 1989;40:268-72.
21. Butterworth AE, Dalton PR, Dunne DW, et al. Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment. Trans R Soc Trop Med Hyg 1984;78:108-23.
22. King CL, Low CC, Nutman TB. IgE production in human helminth infection. Reciprocal interrelationship between IL-4 and IFN-γ. J Immunol 1993;150:1873-80:
23. Finkelman FD, Pearce EJ, Urban JF Jr, Sher A. Regulation and biological function of helminth-induced cytokine responses. Immunol Today 1991;12:A62-6.
24. Wilson RA. Immunity and immunoregulation in helminth infections. Curr Opin Immunol 1993;5:538-47.
25. Pearce EJ, Caspar P, Gryzch JM, Lewis FA. Down-regulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med 1991;173:159-66.
26. Roberts M, Butterworth AE, Kimani G, et al. Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect Immun 1993;61:4984-93.
27. Couissinier-Paris P, Desein AJ. Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2. Eur J Immunol 1995;25:2295-302.
28. Li Z, King CL, Ogundipe JO, Licate LS, Blanton RE. Preferential recognition by human IgE and IgG4 of a species-specific Schistosoma haematobium serine protease inhibitor. J Infect Dis 1995;171:416-22.
29. Stelma FF, Talla I, Polman K, et al. Epidemiology of Schistosoma mansoni in a recently exposed community in northern Senegal. Am J Trop Med Hyg 1993;49:701-6.